The largest database of trusted experimental protocols

Cardiophase

Manufactured by Siemens
Sourced in Germany, United States

CardioPhase is a laboratory equipment product from Siemens. It is designed for cardiac function analysis.

Automatically generated - may contain errors

11 protocols using cardiophase

1

Evaluating Iron Deficiency and Inflammation in COPD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained from all patients at the start of the study protocol. Serum ferritin levels, transferrin saturation, iron levels, and haemoglobin levels were measured in the patients from the Golnik cohort. Subjects were considered iron deficient (ID-COPD) when either absolute iron deficiency (ferritin <100 ng/ml) or functional iron deficiency (ferritin 100–300 ng/ml and transferrin saturation <20%) was present22 (link). Other patients were defined as non-iron deficient (NID-COPD) patients
Serum CRP was determined as a marker for systemic inflammation with the CardioPhase® high-sensitive CRP kit (Siemens Healthcare Diagnostics Inc., Newark, USA) with a lower limit of detection of 0.18 mg/L, in the COPD patients from the Maastricht cohort50 (link). Subjects were considered to have low CRP when CRP ≤ 3.0 mg/L and high CRP when CRP > 3.0 mg/L.
+ Open protocol
+ Expand
2

Blood Sampling and Serum CRP Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the morning (8.00–10.00 a.m.), and after an overnight fast of at least 8 h, the blood samples were collected and subsequently stored at −80 °C until processed.
Serum high-sensitivity (hs) CRP levels were analyzed by CardioPhase® (Siemens Healthcare Diagnostics, Marburg, Germany), based on particle-enhanced immunonephelometry. The coefficient of variation (CV) of intra- and interassay was <7%.
+ Open protocol
+ Expand
3

Blood Sampling and hs-CRP Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected between 8.00–10.00 a.m. after an overnight fast (at least 8 h), and the samples were immediately stored at −80 °C until the assay. hs-CRP levels were assessed by a high-sensitivity nephelometric assay (CardioPhase, Siemens Healthcare Diagnostics, Marburg, Germany). The CV of intra- and interassay was <7%.
+ Open protocol
+ Expand
4

Fasting Blood CRP Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected between 8.00–10.00 a.m. after an overnight fast of at least 8 h, and subsequently stored at −80 °C until processed. High-sensitivity (hs)-CRP levels were determined by a high-sensitivity CardioPhase nephelometric assay of Siemens Healthcare Diagnostics (Marburg, Germany). The CV of intra- and interassay was <7%.
+ Open protocol
+ Expand
5

Biomarker Profiling in Metabolic Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
The blood samples were frozen (− 80 °C) and then assayed in batch. C-Reactive protein (CRP) was measured from plasma using the Siemens CardioPhase hsCRP assay on the BN ProSpec Nephelometer (Siemens Healthcare Diagnostics Products GmbH, Marburd, Germany). The minimal detectable hsCRP concentration was 0.18 mg/L. Lipids and glucose were assayed using respective reagent Flex on the multianalyzer Dimension RxL Max (Dade Behring Diagnostics, Marburg, Germany) with heparinized plasma. To measure waist circumference (WC), the participant’s waistline was exposed and the bottom of a measuring tape was aligned with the top of the hip bone and stretched across the midsection over the navel [50 (link)]. Blood pressure was obtained during a 5-min continuous reading at rest using a Finometer (Finapres Finometer, Amsterdam, the Netherlands) and analyzed offline in LabChart (ADInstruments, Oxford, UK). The mean arterial pressure was used for statistical analyses.
+ Open protocol
+ Expand
6

Measuring Serum hsCRP Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum high-sensitivity C-reactive protein (hsCRP) was measured using particle-enhanced immunonephelometry with CardioPhase® hsCRP on a BN ProSpec System (Siemens Healthcare Diagnostics, Liederbach, Germany). Both the lower limit of detection and lower limit of quantification were equal to 0.175 mg/L according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Measuring High-Sensitivity CRP Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
In a subgroup of participants (n = 207), information on c-reactive protein (CRP) was retrieved from electronic medical records. During each visit, fasting blood samples were collected in the morning (8.00–10.00 a.m.), and stored at − 80 °C until processing. Serum high-sensitivity (hs) CRP concentrations were analyzed by CardioPhase® (Siemens Healthcare Diagnostics, Marburg, Germany), based on particle-enhanced immunonephelometry. The CV of intra-and interassay was < 7%.
+ Open protocol
+ Expand
8

Comprehensive Plasma Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following plasma measurements were performed: glucose (Glucose GOD-PAP, Roche Diagnostics, Mannheim, Germany, coefficient of variation 1.7%, range 241 mg/dL), total cholesterol (CHOD-PAP, Roche Diagnostics, Mannheim, Germany, coefficient of variation 4.0%, range 318 mg/dL), triglycerides (GPO-PAP, Roche Diagnostics, Mannheim, Germany, coefficient of variation 6.4%, range 117 mg/dL), high-density lipoprotein cholesterol (HDL-C) (HDL-C without sample pre-treatment, Roche Diagnostics, Mannheim, Germany, coefficient of variation 4.1%, range 74 mg/dL), HbA1c (Variant II, Bio-Rad Laboratories, Hercules, CA, USA), high-sensitivity C-reactive protein (CRP) (Cardiophase, Dade Behring, Marburg, Germany, coefficient of variation 6.7%, 13.8 g/L). Low-density lipoprotein cholesterol (LDL-C, range 280 mg/dL) was calculated by the Friedewald formula. Technicians, who were blinded to the statin treatment, performed all laboratorial analyses.
+ Open protocol
+ Expand
9

Lipid Profile Changes in STEMI Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Among STEMI patients, blood samples were obtained in the first 24 h from MI symptoms in order to avoid the reported lipid profile changes that occur after this time window [11] (link). Among controls, blood samples were obtained at admission. Blood samples with EDTA were centrifuged after collection at 5 °C and at 4500 rpm for 15 min to separate plasma and cells. Biochemical analyses were performed in duplicates. An automatic chemical analyzer was used to do the following analysis: C-reactive protein (CRP; high-sensitivity assay, Cardiophase, Dade Behring, Marburg, Germany), total cholesterol (CHOD-PAP, Roche Diagnostics, Mannheim, USA), high-density lipoprotein cholesterol (HDL-C, Roche Diagnostics, Mannheim, USA), triglycerides (GPO-PAP, Roche Diagnostics, Mannheim, USA), urea and creatinine (GLDH, Hitachi, Tokyo, Japan). Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula. Glomerular filtration rate (GFR) was estimated by abbreviated MDRD equation: Estimated GFR (mL/min/1.73 m2) = 186 × (creatinine/88.4)− 1.154 × (age) − 0.203 × (0.742, if female) × (1.210, if black) [12] (link).
+ Open protocol
+ Expand
10

Comprehensive Metabolic Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve-hour fasting plasma samples with EDTA were collected at admission and were immediately subjected to biochemical analyses in duplicates using an automatic chemical analyzer (Hitachi 917, Roche-Diagnostics). Glucose (Glucose GOD-PAP, Roche Diagnostics, Mannheim, USA), total cholesterol (CHOD-PAP, Roche Diagnostics, Mannheim, USA), triglycerides (GPO-PAP, Roche Diagnostics, Mannheim, USA), high-density lipoprotein cholesterol (HDL-C) (Roche Diagnostics, Mannheim, USA), high sensitivity C-reactive protein (CRP) (CardioPhase, Dade Behring, Marburg, USA), HbA1c (Variant II, Bio-Rad Laboratories, Hercules, CA, USA), apolipoprotein (apo) AI and B (Behring Nephelometer BNII, Dade Behring, Marburg, Germany) and plasma zinc (Atomic Absorption Spectrometry) were measured. Intra and interassay coefficients of variation for plasma zinc were 2.5% and 5.4%, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!